Key Finding
Pharmacological agents including pregabalin, duloxetine, and α-lipoic acid demonstrated the most consistent efficacy for diabetic neuropathy, with complementary therapies like acupuncture showing preliminary promise requiring further validation.
Diabetic neuropathy is nerve damage that affects up to half of people with diabetes, causing pain, numbness, and balance problems that can lead to foot ulcers and reduced quality of life. Researchers recently reviewed 76 clinical studies published between 2020 and 2025 to understand which treatments work best for diagnosing and managing this condition. The review found that prescription medications like pregabalin and duloxetine were most effective for pain relief, while spinal cord stimulation helped patients who didn't respond to other treatments. Exercise programs improved walking ability and balance, and advanced wound dressings helped heal foot ulcers faster. Importantly, the review identified acupuncture as a complementary therapy showing preliminary promise for diabetic neuropathy symptoms. While acupuncture appears beneficial based on initial evidence, the researchers noted that more rigorous studies are needed to confirm its effectiveness and understand exactly how it helps. For patients with diabetic neuropathy, this research suggests that combining different treatment approaches—including medications, physical therapy, and potentially acupuncture—may offer the best outcomes. The study highlights that managing diabetic neuropathy requires a comprehensive approach tailored to each person's specific symptoms, whether that's pain, balance issues, or foot complications. If you're considering acupuncture for diabetic neuropathy, consult with a licensed acupuncturist experienced in treating diabetes-related complications.
This systematic review synthesized 76 clinical studies (2020-2025) examining diagnostic and therapeutic strategies for diabetic neuropathy, following PRISMA guidelines with data from PubMed, EMBASE, CENTRAL, and Web of Science. Pharmacological interventions—pregabalin, duloxetine, and α-lipoic acid—demonstrated the most consistent efficacy, with significant pain reduction and improved nerve conduction velocity. High-frequency spinal cord stimulation provided sustained pain relief in refractory cases, while exercise-based rehabilitation improved gait velocity and balance parameters. Advanced wound care including platelet-rich plasma dressings and bioengineered skin substitutes accelerated ulcer healing. Acupuncture and balneotherapy were identified as complementary therapies showing preliminary promise but requiring further validation through robust trials. Nerve conduction studies combined with validated scoring instruments remain gold-standard diagnostics, with emerging biomarker and microvascular assessment techniques as adjuncts. Clinical takeaway: Multimodal integration of pharmacological, device-based, and rehabilitative approaches optimizes outcomes, though evidence gaps persist for small-fiber and autonomic neuropathies, warranting controlled research.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 PHN patients show convergent structural gray matter reductions and functional hyperactivation across thalamic, putaminal, cerebellar, and cingulate networks, identifying candidate neuroimaging biomarkers for central sensitization and pain chronicization.
📌 Acupuncture produced significant, clinically meaningful reductions in chronic pain scores while simultaneously modulating key pain-processing brain regions — including the ACC, insula, thalamus, and default mode network — across 17 high-quality RCTs involving 750 patients.
📌 Acupuncture was the most effective non-pharmacological intervention for pelvic pain in women with endometriosis (SMD = −4.53; SUCRA = 99.1%), while physical therapy ranked highest for overall pain relief and dysmenorrhea.